RE:RE:RE:Zero confidence in this CEO And grail is still a year or more away. From the grail article :
Researchers will continue to collect data from the test in large studies across the U.S. The company has also partnered with the U.K.’s National Health Service to pilot the test in approximately 165,000 eligible patients, starting later this year.
LittleGuy2 wrote: With all respect, you're missing the point...even with superior sensitivity & specificity, we, (speaking as a long), are being vastly outpaced by an inferior product. Promote the tech, just get new leadership. The new acquisition is not a group of research physicians, just a bunch of clinicians taking the opportunity to add a new frill to bill.